Research Progress on Natural Plant Molecules in Regulating the Blood–Brain Barrier in Alzheimer’s Disease
Molecules · 16.11.2023 · 28 (22) · 7631
DOI: 10.3390/molecules28227631 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 16.11.2023. Verfasst von Weidong Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Basic Theory of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder. With the aging population and the continuous development of risk factors associated with AD, it will impose a significant burden on individuals, families, and society. Currently, commonly used therapeutic drugs such as Cholinesterase inhibitors, N-methyl-D-aspartate antagonists, and multiple AD pathology removal drugs have been shown to have beneficial effects on certain pathological conditions of AD. However, their clinical efficacy is minimal and they are associated with certain adverse reactions. Furthermore, the underlying pathological mechanism of AD remains unclear, posing a challenge for drug development. In contrast, natural plant molecules, widely available, offer multiple targeting pathways and demonstrate inherent advantages in modifying the typical pathologic features of AD by influencing the blood–brain barrier (BBB). We provide a comprehensive review of recent in vivo and in vitro studies on natural plant molecules that impact the BBB in the treatment of AD. Additionally, we analyze their specific mechanisms to offer novel insights for the development of safe and effective targeted drugs as well as guidance for experimental research and the clinical application of drugs for the prevention and treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Basic Theory of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
- Department of Chinese Pharmacology, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
- Science and Education Section, Zhangjiakou First Hospital, Zhangjiakou 075041, China.
- Department of Internal Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Wu, W., Huang, J., Han, P., Zhang, J., Wang, Y., Jin, F., & Zhou, Y. (2023). Research Progress on Natural Plant Molecules in Regulating the Blood–Brain Barrier in Alzheimer’s Disease. Molecules, 28(22), 7631. https://doi.org/10.3390/molecules28227631
Vancouver
Wu W, Huang J, Han P, Zhang J, Wang Y, Jin F, et al. Research Progress on Natural Plant Molecules in Regulating the Blood–Brain Barrier in Alzheimer’s Disease. Molecules. 2023;28(22):7631. doi:10.3390/molecules28227631
BibTeX
@article{Wu2023,
author = {Wu, Weidong and Huang, Jiahao and Han, Pengfei and Zhang, Jian and Wang, Yuxin and Jin, Fangfang and Zhou, Yanyan},
title = {Research Progress on Natural Plant Molecules in Regulating the Blood–Brain Barrier in Alzheimer’s Disease},
journal = {Molecules},
year = {2023},
volume = {28},
number = {22},
pages = {7631},
doi = {10.3390/molecules28227631}
}
EUVIMED